Antibacterial susceptibility uropathogens in 3 hospitals, Sari, Islamic Republic of Iran, 2002-2003

Eastern Mediterranean Health Journal

Volumn 14, Issue 3, 2008, Pages 556-563

  Saffar, M J ^a   Enayti, A A ^a   Abdolla, I A ^a   Razai, M S ^a   Saffar, H ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPICILLIN; CEFALEXIN; CEFAZOLIN; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; QUINOLONE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; ENTEROBACTER; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN; OUTPATIENT; PSEUDOMONAS; STAPHYLOCOCCUS; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; URINE CULTURE;

ADULT; CHI-SQUARE DISTRIBUTION; CHILD; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT, NEWBORN; IRAN; MALE; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; STAPHYLOCOCCAL INFECTIONS; URINALYSIS; URINARY TRACT INFECTIONS;

EID: 48249113025     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bacheller CD, Bernstein JM. Urinary tract infection. Medical clinics of North America, 1997, 81(3):719-30.
2. Kalsi J et al. Hospital-acquired urinary tract infection. International journal of clinical practice, 2003, 57(5):388-91.
3. Hoberman A, Wald ER. Urinary tract infection in young febrile children. Pediatric infectious disease journal, 1997, 16(l):11-7.
4. Orrett FA et al. Paediatric nosocomial urinary tract infection at a regional hospital. International urology and nephrology, 1999, 31(2):173-9.
5. Gupta K et al. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clinical infectious-diseases, 2001, 33(1):89-94.
6. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Disease-a-month, 2003, 49(2):53-70.
7. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. The diagnosis, treatment, and evaluation of the initial UTI in febrile infants and young children. Pediatrics, 1999, 103:843-52.
8. Sefton AM. The impact of resistance on the management of urinary tract infection. International journal of antimicrobial agents, 2000, 16:489-91.
9. Gupta K. Emerging antibiotic resistance in urinary tract infections. Infectious disease clinics of North America, 2003,17(2):243-59.
10. Chomarat M. Resistance of bacterial in urinary tract infections. International journal of antimicrobial agents, 2000, 16:483-7.
11. Prais D et al. Bacterial susceptibility to oral antibiotics in community acquired urinary tract infections. Archives of disease in childhood, 2003, 88(2):215-8.
12. Gordon KA, Jones RA, SENTRY Participant Groups Europe, LA. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagnostic microbiology and infectious disease, 2003, 45:295-301.
13. Opal SM, Mayer KH, Medioras AA. Mecanisms of bacterial resistance. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and practice of infectious diseases, 5th ed. New York, Churchill Livingstone, 2000:239-53.
14. Reisner BS et al. Specimen processing. In: Murray PR et al. Manual of clinical microbiology, 7th ed. Washington DC, American Society for Microbiology Press. 1999:75-6.
15. Leblebicioglu H, Esen S, Turkish Nosocomial Urinary Tract Infection Study Group. Hospital-acquired urinary tract infection in Turkey: a nationwide multicenter point prevalence study. Journal of hospital infection, 2003, 53(3):207-10.
16. Landhani S, Grandsen W. Increasing antibiotic resistance among urinary tract isolates. Archives of disease in childhood, 2003,88(5):444-5.
17. Wazait HD et al. Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996-2001). BJU international, 2003, 91(9):806-9.
18. Daza R, Gutierrez J, Piedrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. International journal of antimicrobial agents, 2001, 18:11-5.
19. Sobel JD, Vazquez JA. Fungal bacterial susceptibility to oral antibiotics in community infections of the urinary tract. World journal of urology, 1999, 17(6):410-4.
20. Fegin RD et al., eds. Textbook of pediatric infectious diseases, 5th ed. Philadelphia, WB Saunders, 2004:1175-92, 2573.
21. Orrett FA, Shurland SM. The changing patterns of antimicrobial susceptibility of urinary pathogens in Trinidad. Singapore medical journal, 1998,39:256-9.
22. Raz R et al. Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in Northern Israel. Israel medical association journal, 2000,2(6):426-9.
23. Gur D, Unal S. Resistance to antimicrobial agents in Mediterranean countries. International journal of antimicrobial agents, 2001, 17:21-6.
24. Dietrich DW, Auld BB, Mermel LA. Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children. Pediatrics, 2004, 113:347e.